Research suggests that IRF7 may also inhibit the expression of genes that promote tumour proliferation, invasion and metastasis through direct or indirect mechanisms, such as by regulating the expression of cell cycle proteins and apoptosis inhibitors such as members of the Bcl‐2 family, thereby altering the survival and proliferation capabilities of cancer cells.42 The gene discussed is PROS1; the disease is neoplasm.